NANOVIRICIDES, INC.
Financial highlights
| Metric | FY June 30, 2025 | FY June 30, 2024 | FY June 30, 2023 | FY June 30, 2022 | FY June 30, 2021 |
|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | — | — |
| Operating income | -$9.6M | -$8.5M | -$8.9M | -$8.1M | -$8.7M |
| Operating expenses | $9.6M | $8.5M | $8.9M | $8.1M | $8.7M |
| Cash from operations | -$8.5M | -$6.3M | -$5.7M | -$5.9M | -$8.2M |
| Capital expenditure | $56,964 | $156,560 | $151,712 | $324,348 | $238,765 |
| Free cash flow | -$8.5M | -$6.5M | -$5.8M | -$6.2M | -$8.5M |
| Total assets | $8.8M | $12.8M | $16.9M | $23.5M | $30.3M |
| Total liabilities | $1.3M | $1.4M | $2.0M | $412,837 | — |
Shares outstanding 21.6M · Free float 45.1%
Annual filing data through FY ended June 30, 2025; float as of July 13, 2026.